Indications & Uses
Eczacort is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
For corticosteroid-responsive dermatoses in adults, apply a thin film to the affected skin areas two or three times daily, depending on the severity of the condition, and rub in gently. For atopic dermatitis in patients 3 months to 18 years of age, apply a thin film to the affected skin areas two times daily, and rub in gently. Do not apply hydrocortisone butyrate in the diaper area unless directed by a physician. Discontinue therapy when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Before prescribing for more than 2 weeks, any additional benefits of extending treatment to 4 weeks should be weighed against the risk of HPA axis suppression and local adverse events. The safety and efficacy of hydrocortisone butyrate has not been established beyond 4 weeks of use. Do not use hydrocortisone butyrate with occlusive dressings unless directed by a physician. Avoid use in the diaper area, as diapers or plastic pants may constitute occlusive dressings.Pediatric use: Safety and efficacy in pediatric patients below 3 months of age have not been established.Geriatric use: Safety and efficacy in geriatric patients over 65 years of age have not been established.
Side Effects
Stinging, burning, itching, irritation, dryness, or redness at the application site may occur when thismedication is first applied to the skin. These effects should disappear in a few days as body adjusts to themedication.
Cautions & Contraindications
Warnings & Precautions
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal(HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in somepatients. Conditions which augment systemic absorption include the application of the more potentcorticosteroids, use over large surface areas, prolonged use, and the addition of occlusive dressings.Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptibleto systemic toxicity. If irritation develops, topical corticosteroids should be discontinued and appropriatetherapy instituted. In the presence of dermatological infections, the use of an appropriate antifungal orantibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroidshould be discontinued until the infection has been adequately controlled.
Contraindications
Hydrocortisone Butyrate is contraindicated in those patients with a history of sensitivity reactions to any ofits active ingredients.